Enoxaparin Sodium Injection, Solution
Product Images NDC 81952-126

Product Visual Gallery

This gallery contains 45 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 81952-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hepalink Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-blister-label (100mg Bister Label)

Enoxaparin Sodium Injection, USP 100 mg/1 mL subcutaneous injection in a single-dose syringe with an automatic safety device. The label displays dosage, storage, and warning information, indicating use for subcutaneous administration only. Distributed by Hepalink USA Inc., the label includes NDC 81952-130-01 and storage instructions at 25°C (77°F) with permitted excursions. Issued February 2023.*

FDA Label Image

100mg-carton (100mg Carton)

Flat carton packaging label for Enoxaparin Sodium Injection USP 100 mg/1 mL subcutaneous injection by Techdow USA, a Hepalink Company. The label indicates ten 1 mL single-dose syringes with automatic safety devices. Storage and handling instructions, manufacturer contact information, and origin details are also visible, along with multiple barcodes.*

FDA Label Image

100mg-syringe-label (100mg Syringe Label)

Label for Enoxaparin Sodium Injection, USP 100 mg/mL solution for subcutaneous injection. The label includes the NDC number 81952-130-01 and indicates manufacturing in China for Hepalink USA Inc. It shows the Techdow logo and space for lot and expiration date information. The label is marked Rx only.*

FDA Label Image

120mg-blister-label (120mg Blister Label)

Labels for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL subcutaneous injection syringes by Hepalink USA Inc. Each label includes the product name, strength, single-dose syringe with automatic safety device, usage instructions, storage conditions, barcode, and company contact information. Labels are arranged in a sheet with perforated peel lines.*

FDA Label Image

120mg-carton (120mg Carton)

This is a carton label for Enoxaparin Sodium Injection, USP, 120 mg/0.8 mL, a subcutaneous injection solution. The label indicates ten 0.8 mL single-dose syringes with an automatic safety device. The product is distributed by Hepalink USA Inc. and manufactured by Techdow USA. The label includes storage instructions, dosage information, and regulatory details including an NDC number and barcodes.*

FDA Label Image

120mg-syringe-label (120mg Syringe Label)

Label for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL subcutaneous injection by Techdow. The label shows the NDC code 81952-132-18 and states the product is manufactured in China for Hepalink USA Inc. It includes space for lot and expiration date information, and features barcodes on left and right sides.*

FDA Label Image

150mg-blister-label (150mg Blister Label)

Labels for Enoxaparin Sodium Injection, USP 150 mg/mL by Hepalink USA Inc. The labels specify it is for subcutaneous use, with each 1 mL single-dose syringe featuring an automatic safety device. The label includes dosage information, storage instructions, and a warning to keep out of reach of children. Distributed by Hepalink USA, Langhorne, PA.*

FDA Label Image

150mg-carton (150mg Carton)

Carton packaging label for Enoxaparin Sodium Injection, USP 150 mg/1 mL solution for subcutaneous use. The cartons display the product name, strength, and dosage form, stating that it contains ten 1 mL single-dose syringes with an automatic safety device. The labeler is Techdow USA, a Hepalink company. Additional storage and usage instructions are provided on the side panel.*

FDA Label Image

150mg-syringe-label (150mg Syringe Label)

Label for Enoxaparin Sodium Injection, USP 150 mg/1 mL by Hepalink USA Inc. The label indicates the product is for subcutaneous injection, manufactured in China for Hepalink USA. It includes the NDC number 81952-135-01 and a lot and expiration date section.*

FDA Label Image

30mg-blister-label (30mg Blister Label)

Label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL, a subcutaneous injection presented in a single-dose syringe with an automatic safety device. The label includes storage instructions at 25°C with permitted excursions, a warning to keep out of reach of children, and distributor information for Hepalink USA Inc. Each label features the Techdow USA logo and NDC 81952-123-13.*

FDA Label Image

30mg-carton (30mg Carton)

Box packaging label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL, a subcutaneous injection solution. The box indicates it contains ten 0.3 mL single-dose syringes with automatic safety device. The labeler is Hepalink USA Inc., marketed under Techdow USA. The label includes storage instructions, warnings, and manufacturer information.*

FDA Label Image

30mg-syringe-label (30mg Syringe Label)

Label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL subcutaneous injection by Hepalink USA Inc. The label includes a barcode, NDC number 81952-123-13, and indicates manufacturing in China for Hepalink USA Inc. The product is Rx only and includes space for lot and expiration dates.*

FDA Label Image

40mg-blister-label (40mg Blister Label)

Label for Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL in a single-dose syringe with an automatic safety device. Intended for subcutaneous use, Rx only. Distributed by Hepalink USA Inc. Instructions include dosage and storage at 25°C with permitted excursions. Issued date is 02/2023. The label is repeated in a sheet format with peelable tabs.*

FDA Label Image

40mg-carton (40mg Carton)

Carton label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL subcutaneous injection, distributed by Hepalink USA Inc., a Techdow USA company. The package contains ten 0.4 mL single-dose syringes with an automatic safety device. The label includes storage instructions, manufacturer information, and barcodes.*

FDA Label Image

40mg-syringe-label (40mg Syringe Label)

Label for Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL solution for subcutaneous injection. It is manufactured in China for Hepalink USA Inc. The label includes the NDC 81952-124-14 and the Techdow logo, with space for lot and expiration date information.*

FDA Label Image

60mg-blister-label (60mg Blister Label)

Label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL subcutaneous injection by Techdow USA, a Hepalink company. The label states it is Rx only, for single-dose use with an automatic safety device, and provides storage instructions, dosing information, distributor contact details (Hepalink USA Inc.), and the NDC 81952-126-16. The text repeats multiple times on the sheet for packaging purposes.*

FDA Label Image

60mg-carton (60mg Carton)

Packaging label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL solution for subcutaneous use. The label indicates ten 0.6 mL single-dose syringes with automatic safety devices. Distributed by Hepalink USA Inc., the box design shows branding from Techdow USA and includes storage, dosage, and safety information.*

FDA Label Image

60mg-syringe-label (60mg Syringe Label)

Label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL subcutaneous injection. The label includes the NDC number 81952-126-16 and states it is manufactured in China for Hepalink USA Inc. The brand Techdow is also mentioned. Lot and expiration date fields are present but not filled.*

FDA Label Image

80mg-blister-label (80mg Blister Label)

Label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL by Techdow USA. The label indicates the product is for subcutaneous use, supplied as a single-dose syringe with an automatic safety device. It includes storage instructions, dosage information, warnings, and distributor contact details for Hepalink USA Inc., Langhorne, PA.*

FDA Label Image

80mg-carton (80mg Carton)

Packaging label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL, a subcutaneous injection. The carton indicates ten 0.8 mL single-dose syringes with automatic safety device. Distributed by Hepalink USA Inc., the label includes storage and usage instructions, barcode, and manufacturer Techdow USA Co., Ltd.*

FDA Label Image

80mg-syringe-label (80mg Syringe Label)

Label of Enoxaparin Sodium Injection, USP 80 mg/0.8 mL solution for subcutaneous injection. The label shows Rx only status, manufacturer as Hepalink USA Inc., and states it is made in China. The label includes lot and expiration date fields, a barcode, and the Techdow trademark.*

FDA Label Image

Enoxaparin-fig6 (Enoxaparin Fig6)

A forest plot chart comparing the relative risk of various patient subgroups treated with Enoxaparin Sodium (Enox) versus unfractionated heparin (UFH). The chart lists subgroups by sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent used, time to treatment, and PCI status, showing relative risk values and percentages for UFH and Enox, along with the reduction in risk. The overall relative risk favors Enoxaparin.*

FDA Label Image

Enoxaparin-fig7 (Enoxaparin Fig7)

A Kaplan-Meier-type plot displaying hazard distribution function over time (days) to death or myocardial re-infarction for Enoxaparin versus UFH (unfractionated heparin). The graph includes a log-rank test p-value and a smaller inset zooming in on the 1-year data. A risk table is shown below the time axis for both groups.*

FDA Label Image

Enoxaparin-str1 (Enoxaparin Str1)

Chemical structure of Enoxaparin Sodium showing repeating units with variable groups R1 (H or SO3Na) and R2 (SO3Na or COCH3). The diagram depicts the polysaccharide backbone characteristic of this anticoagulant drug.*

FDA Label Image

Enoxaparin-str2 (Enoxaparin Str2)

Chemical structure diagram of Enoxaparin Sodium, showing its molecular components and arrangement as depicted in the image.*

FDA Label Image

Figure-a (Figure A)

An instructional illustration labeled 'Figure A' showing two hands preparing a syringe for injection, with arrows indicating the steps to remove or connect a small cap or component of the syringe.*

FDA Label Image

Figure-b (Figure B)

An instructional diagram labeled Figure B showing hands administering a subcutaneous injection using a syringe or prefilled pen device. The illustration highlights the technique of injecting just under the skin, consistent with the subcutaneous route for Enoxaparin Sodium injection.*

FDA Label Image

Figure-c (Figure C)

An instructional diagram labeled Figure C showing a hand holding a prefilled syringe with the needle positioned close to the skin, indicating preparation or administration of a subcutaneous injection.*

FDA Label Image

Figure-d (Figure D)

An instructional line drawing labeled Figure D showing a hand holding a syringe, demonstrating how to position the thumb and fingers to operate or prepare the syringe for use.*

FDA Label Image

Figure-e (Figure E)

An instructional diagram showing a gloved hand disposing of a syringe into a container labeled 'BIOHAZARD.' The image illustrates safe disposal practices for injection equipment, relevant to the subcutaneous injection administration of Enoxaparin Sodium.*

FDA Label Image

Instruction-for-us-figure-a (Instruction For Us Figure A)

An instructional diagram showing components for administering Enoxaparin Sodium injection. It labels a Lovenox prefilled syringe, a cotton ball or gauze, a sharps disposal container, an alcohol wipe, and a small adhesive bandage, illustrating the items typically used in a subcutaneous injection procedure.*

FDA Label Image

Instruction-for-us-figure-b (Instruction For Us Figure B)

An instructional illustration showing a person peeling or removing a protective backing from a strip or patch, holding an injection pen or syringe in the other hand. The image appears to be guidance on preparing or using a subcutaneous injection device.*

FDA Label Image

Instruction-for-us-figure-c (Instruction For Us Figure C)

An instructional diagram showing a syringe with a black plunger, a transparent barrel, and a needle cap. The syringe is labeled with a section indicating where to find the expiration date. This image is related to the Enoxaparin Sodium injection, solution product.*

FDA Label Image

Instruction-for-us-figure-d (Instruction For Us Figure D)

An illustration showing a syringe filled with a clear liquid labeled as Enoxaparin Sodium injection solution. The syringe is shown with a needle attached, and the liquid is visibly clear inside the barrel, consistent with subcutaneous injection use.*

FDA Label Image

Instruction-for-us-figure-e (Instruction For Us Figure E)

An anatomical illustration depicting the recommended subcutaneous injection sites for Enoxaparin Sodium injection. The shaded areas on the abdomen indicate the preferred locations to administer the injection.*

FDA Label Image

Instruction-for-us-figure-f (Instruction For Us Figure F)

An instructional illustration depicting a hand holding a cleansing swab and preparing to clean the abdominal area above the waistband. This image is associated with the subcutaneous injection of Enoxaparin Sodium.*

FDA Label Image

Instruction-for-us-figure-g (Instruction For Us Figure G)

Instructional illustration showing a person using both hands to remove a needle cap from a syringe filled with Enoxaparin Sodium injection solution. The syringe is held in the right hand, and the cap is being pulled straight off with the left hand, indicated by directional arrows.*

FDA Label Image

Instruction-for-us-figure-h (Instruction For Us Figure H)

An instructional illustration showing a hand holding a pre-filled syringe of Enoxaparin Sodium injection solution. The image demonstrates how to set the dose by adjusting the syringe plunger downward to the desired measurement level.*

FDA Label Image

Instruction-for-us-figure-i (Instruction For Us Figure I)

An instructional diagram showing a hand giving a subcutaneous injection into the abdominal area, specifically below the navel. The image highlights the correct injection site for an Enoxaparin Sodium subcutaneous injection.*

FDA Label Image

Instruction-for-us-figure-j (Instruction For Us Figure J)

A black-and-white instructional illustration showing how to administer a subcutaneous injection. The image depicts a hand holding a syringe at a 90-degree angle to the skin of the abdomen, with an arrow pointing to the injection site and a diagram indicating the correct injection angle.*

FDA Label Image

Instruction-for-us-figure-k (Instruction For Us Figure K)

An instructional diagram showing a hand administering a subcutaneous injection with a syringe to the abdomen. The illustration demonstrates proper injection technique for a subcutaneous injection, with one hand pinching the skin and the other holding the syringe needle at a 90-degree angle to the injection site.*

FDA Label Image

Instruction-for-us-figure-l (Instruction For Us Figure L)

An instructional illustration showing a hand performing a subcutaneous injection into the abdomen area. It depicts the hand positioning the syringe at the injection site near the lower abdomen, with a thumb pinching the skin to create a fold for the injection.*

FDA Label Image

Instruction-for-us-figure-m (Instruction For Us Figure M)

An instructional illustration showing a hand holding an Enoxaparin Sodium prefilled syringe. The diagram highlights a protective sleeve around the syringe and includes an arrow indicating a 'click' action to engage or activate the sleeve mechanism.*

FDA Label Image

Instruction-for-us-figure-n (Instruction For Us Figure N)

An instructional illustration showing a hand placing an Enoxaparin Sodium prefilled syringe into a sharps disposal container. The syringe and needle cap are labeled, emphasizing proper disposal of the injection device after subcutaneous use.*

FDA Label Image

Instruction-for-us-figure (Instruction For Us Figure)

An instructional diagram depicting the use of a syringe before and after injection. Before use, the syringe includes a plunger rod, needle, and needle cap. After use, the plunger rod is fully depressed, and a protective sleeve covers the needle.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.